|
|
Volumn 26, Issue 3, 2012, Pages 157-162
|
|
Short-term effectiveness of intravitreal bevacizumab vs. ranibizumab injections for patients with polypoidal choroidal vasculopathy.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANGIOGENESIS INHIBITOR;
BEVACIZUMAB;
MONOCLONAL ANTIBODY;
RANIBIZUMAB;
VASCULOTROPIN A;
ARTICLE;
CHOROID;
CHOROID DISEASE;
CLINICAL TRIAL;
COMPARATIVE STUDY;
DOSE RESPONSE;
DRUG ANTAGONISM;
EYE FUNDUS;
FEMALE;
FLUORESCENCE ANGIOGRAPHY;
FOLLOW UP;
HUMAN;
INTRAVITREAL DRUG ADMINISTRATION;
MALE;
MIDDLE AGED;
OPTICAL COHERENCE TOMOGRAPHY;
PATHOLOGY;
PATHOPHYSIOLOGY;
PERIPHERAL VASCULAR DISEASE;
RETINA FOVEA;
RETROSPECTIVE STUDY;
TIME;
TREATMENT OUTCOME;
VASCULARIZATION;
VISUAL ACUITY;
ANGIOGENESIS INHIBITORS;
ANTIBODIES, MONOCLONAL, HUMANIZED;
CHOROID;
CHOROID DISEASES;
DOSE-RESPONSE RELATIONSHIP, DRUG;
FEMALE;
FLUORESCEIN ANGIOGRAPHY;
FOLLOW-UP STUDIES;
FOVEA CENTRALIS;
FUNDUS OCULI;
HUMANS;
INTRAVITREAL INJECTIONS;
MALE;
MIDDLE AGED;
PERIPHERAL VASCULAR DISEASES;
RETROSPECTIVE STUDIES;
TIME FACTORS;
TOMOGRAPHY, OPTICAL COHERENCE;
TREATMENT OUTCOME;
VASCULAR ENDOTHELIAL GROWTH FACTOR A;
VISUAL ACUITY;
|
|
EID: 84866925726
PISSN: 10118942
EISSN: None
Source Type: Journal
DOI: 10.3341/kjo.2012.26.3.157 Document Type: Article |
|
Times cited : (27)
|
|
References (0)
|
